Logo image of PHI

PLDT INC-SPON ADR (PHI) Stock Fundamental Analysis

NYSE:PHI - New York Stock Exchange, Inc. - US69344D4088 - ADR - Currency: USD

22.8  -0.43 (-1.85%)

Fundamental Rating

5

Taking everything into account, PHI scores 5 out of 10 in our fundamental rating. PHI was compared to 21 industry peers in the Wireless Telecommunication Services industry. PHI has an excellent profitability rating, but there are concerns on its financial health. PHI has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year PHI was profitable.
PHI had a positive operating cash flow in the past year.
PHI had positive earnings in each of the past 5 years.
PHI had a positive operating cash flow in each of the past 5 years.
PHI Yearly Net Income VS EBIT VS OCF VS FCFPHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B 60B 80B

1.2 Ratios

The Return On Assets of PHI (5.02%) is better than 71.43% of its industry peers.
PHI has a Return On Equity of 27.25%. This is amongst the best in the industry. PHI outperforms 95.24% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.10%, PHI is in the better half of the industry, outperforming 76.19% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for PHI is in line with the industry average of 6.35%.
The 3 year average ROIC (5.82%) for PHI is below the current ROIC(9.10%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.02%
ROE 27.25%
ROIC 9.1%
ROA(3y)3.73%
ROA(5y)3.92%
ROE(3y)20.92%
ROE(5y)21.02%
ROIC(3y)5.82%
ROIC(5y)6.78%
PHI Yearly ROA, ROE, ROICPHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

PHI has a Profit Margin of 14.44%. This is amongst the best in the industry. PHI outperforms 95.24% of its industry peers.
In the last couple of years the Profit Margin of PHI has grown nicely.
PHI's Operating Margin of 24.45% is amongst the best of the industry. PHI outperforms 95.24% of its industry peers.
In the last couple of years the Operating Margin of PHI has remained more or less at the same level.
PHI has a Gross Margin of 86.73%. This is amongst the best in the industry. PHI outperforms 90.48% of its industry peers.
In the last couple of years the Gross Margin of PHI has remained more or less at the same level.
Industry RankSector Rank
OM 24.45%
PM (TTM) 14.44%
GM 86.73%
OM growth 3Y1.9%
OM growth 5Y0.33%
PM growth 3Y2.8%
PM growth 5Y2.3%
GM growth 3Y-1.41%
GM growth 5Y-0.63%
PHI Yearly Profit, Operating, Gross MarginsPHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PHI is creating value.
PHI has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, PHI has about the same amount of shares outstanding.
The debt/assets ratio for PHI is higher compared to a year ago.
PHI Yearly Shares OutstandingPHI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
PHI Yearly Total Debt VS Total AssetsPHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

2.2 Solvency

Based on the Altman-Z score of 0.81, we must say that PHI is in the distress zone and has some risk of bankruptcy.
PHI has a worse Altman-Z score (0.81) than 66.67% of its industry peers.
The Debt to FCF ratio of PHI is 20.01, which is on the high side as it means it would take PHI, 20.01 years of fcf income to pay off all of its debts.
PHI's Debt to FCF ratio of 20.01 is on the low side compared to the rest of the industry. PHI is outperformed by 66.67% of its industry peers.
A Debt/Equity ratio of 2.68 is on the high side and indicates that PHI has dependencies on debt financing.
PHI's Debt to Equity ratio of 2.68 is on the low side compared to the rest of the industry. PHI is outperformed by 80.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.68
Debt/FCF 20.01
Altman-Z 0.81
ROIC/WACC3.33
WACC2.73%
PHI Yearly LT Debt VS Equity VS FCFPHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B 300B

2.3 Liquidity

A Current Ratio of 0.36 indicates that PHI may have some problems paying its short term obligations.
PHI's Current ratio of 0.36 is on the low side compared to the rest of the industry. PHI is outperformed by 95.24% of its industry peers.
A Quick Ratio of 0.35 indicates that PHI may have some problems paying its short term obligations.
PHI has a worse Quick ratio (0.35) than 95.24% of its industry peers.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.35
PHI Yearly Current Assets VS Current LiabilitesPHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

3

3. Growth

3.1 Past

PHI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.33%.
The Earnings Per Share has been growing slightly by 5.18% on average over the past years.
Looking at the last year, PHI shows a small growth in Revenue. The Revenue has grown by 2.38% in the last year.
The Revenue has been growing slightly by 5.09% on average over the past years.
EPS 1Y (TTM)3.33%
EPS 3Y5.37%
EPS 5Y5.18%
EPS Q2Q%-3.92%
Revenue 1Y (TTM)2.38%
Revenue growth 3Y4.1%
Revenue growth 5Y5.09%
Sales Q2Q%-1.76%

3.2 Future

The Earnings Per Share is expected to grow by 3.80% on average over the next years.
The Revenue is expected to grow by 2.78% on average over the next years.
EPS Next Y3.96%
EPS Next 2Y4.64%
EPS Next 3Y3.8%
EPS Next 5YN/A
Revenue Next Year2.01%
Revenue Next 2Y2.3%
Revenue Next 3Y2.78%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PHI Yearly Revenue VS EstimatesPHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50B 100B 150B 200B
PHI Yearly EPS VS EstimatesPHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50 100 150

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.20, the valuation of PHI can be described as very reasonable.
PHI's Price/Earnings ratio is rather cheap when compared to the industry. PHI is cheaper than 85.71% of the companies in the same industry.
PHI is valuated cheaply when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 7.42 indicates a rather cheap valuation of PHI.
85.71% of the companies in the same industry are more expensive than PHI, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.36, PHI is valued rather cheaply.
Industry RankSector Rank
PE 8.2
Fwd PE 7.42
PHI Price Earnings VS Forward Price EarningsPHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PHI is valued a bit cheaper than 71.43% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, PHI is valued a bit more expensive than 61.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.87
EV/EBITDA 5.51
PHI Per share dataPHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PHI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.07
PEG (5Y)1.58
EPS Next 2Y4.64%
EPS Next 3Y3.8%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.37%, PHI is a good candidate for dividend investing.
PHI's Dividend Yield is rather good when compared to the industry average which is at 56.11. PHI pays more dividend than 85.71% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, PHI pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.37%

5.2 History

The dividend of PHI has a limited annual growth rate of 5.62%.
PHI has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)5.62%
Div Incr Years0
Div Non Decr Years0
PHI Yearly Dividends per sharePHI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

66.05% of the earnings are spent on dividend by PHI. This is not a sustainable payout ratio.
PHI's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP66.05%
EPS Next 2Y4.64%
EPS Next 3Y3.8%
PHI Yearly Income VS Free CF VS DividendPHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B -20B 30B
PHI Dividend Payout.PHI Dividend Payout, showing the Payout Ratio.PHI Dividend Payout.PayoutRetained Earnings

PLDT INC-SPON ADR

NYSE:PHI (8/6/2025, 7:00:00 PM)

22.8

-0.43 (-1.85%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)05-15 2025-05-15
Earnings (Next)08-12 2025-08-12
Inst Owners5.1%
Inst Owner Change-0.76%
Ins Owners0.81%
Ins Owner ChangeN/A
Market Cap4.93B
Analysts82.5
Price Target30.41 (33.38%)
Short Float %0.23%
Short Ratio3.31
Dividend
Industry RankSector Rank
Dividend Yield 7.37%
Yearly Dividend1.66
Dividend Growth(5Y)5.62%
DP66.05%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-12 2025-03-12 (0.821086)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.41%
Min EPS beat(2)-0.58%
Max EPS beat(2)5.39%
EPS beat(4)1
Avg EPS beat(4)-0.1%
Min EPS beat(4)-4.35%
Max EPS beat(4)5.39%
EPS beat(8)5
Avg EPS beat(8)6.64%
EPS beat(12)9
Avg EPS beat(12)13.5%
EPS beat(16)13
Avg EPS beat(16)13.58%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.79%
PT rev (3m)-3.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.63%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.47%
Revenue NY rev (3m)-0.93%
Valuation
Industry RankSector Rank
PE 8.2
Fwd PE 7.42
P/S 1.3
P/FCF 16.87
P/OCF 3.44
P/B 2.46
P/tB 5.57
EV/EBITDA 5.51
EPS(TTM)2.78
EY12.19%
EPS(NY)3.07
Fwd EY13.48%
FCF(TTM)1.35
FCFY5.93%
OCF(TTM)6.62
OCFY29.05%
SpS17.49
BVpS9.27
TBVpS4.09
PEG (NY)2.07
PEG (5Y)1.58
Profitability
Industry RankSector Rank
ROA 5.02%
ROE 27.25%
ROCE 12.14%
ROIC 9.1%
ROICexc 9.41%
ROICexgc 11.1%
OM 24.45%
PM (TTM) 14.44%
GM 86.73%
FCFM 7.73%
ROA(3y)3.73%
ROA(5y)3.92%
ROE(3y)20.92%
ROE(5y)21.02%
ROIC(3y)5.82%
ROIC(5y)6.78%
ROICexc(3y)6.02%
ROICexc(5y)7.44%
ROICexgc(3y)7.16%
ROICexgc(5y)9.04%
ROCE(3y)7.76%
ROCE(5y)9.05%
ROICexcg growth 3Y-2.13%
ROICexcg growth 5Y-4.68%
ROICexc growth 3Y-0.98%
ROICexc growth 5Y-2.62%
OM growth 3Y1.9%
OM growth 5Y0.33%
PM growth 3Y2.8%
PM growth 5Y2.3%
GM growth 3Y-1.41%
GM growth 5Y-0.63%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 2.68
Debt/FCF 20.01
Debt/EBITDA 2.79
Cap/Depr 114.01%
Cap/Sales 30.14%
Interest Coverage 4.67
Cash Conversion 74.42%
Profit Quality 53.51%
Current Ratio 0.36
Quick Ratio 0.35
Altman-Z 0.81
F-Score6
WACC2.73%
ROIC/WACC3.33
Cap/Depr(3y)117.23%
Cap/Depr(5y)139.41%
Cap/Sales(3y)38.48%
Cap/Sales(5y)42.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.33%
EPS 3Y5.37%
EPS 5Y5.18%
EPS Q2Q%-3.92%
EPS Next Y3.96%
EPS Next 2Y4.64%
EPS Next 3Y3.8%
EPS Next 5YN/A
Revenue 1Y (TTM)2.38%
Revenue growth 3Y4.1%
Revenue growth 5Y5.09%
Sales Q2Q%-1.76%
Revenue Next Year2.01%
Revenue Next 2Y2.3%
Revenue Next 3Y2.78%
Revenue Next 5YN/A
EBIT growth 1Y21%
EBIT growth 3Y6.08%
EBIT growth 5Y5.44%
EBIT Next Year100.03%
EBIT Next 3Y29.59%
EBIT Next 5YN/A
FCF growth 1Y265.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2.11%
OCF growth 3Y-3.86%
OCF growth 5Y3.33%